Dna Replication and Repair PDF
Dna Replication and Repair PDF
Dna Replication and Repair PDF
❑DNA pol I also has a 5′→ 3′ exonuclease activity that is able to hydrolytically remove the
RNA primer.
❑First, DNA pol I locates the space (nick) between the 3′-end of the DNA newly synthesized
by DNA pol III and the 5′-end of the adjacent RNA primer.
❑Next, DNA pol I hydrolytically removes the RNA nucleotides ahead of itself, moving in the
5′→ 3′ direction (5′→ 3′ exonuclease activity).
RNA primer excision and replacement by DNA continued…..
❑As it removes ribonucleotides, DNA pol I replaces them with
deoxyribonucleotides, synthesizing DNA in the 5′→ 3′ direction (5′→ 3′
polymerase activity).
❑As it synthesizes the DNA, it also proofreads using its 3′→ 5′ exonuclease
activity to remove errors.
❑This removal/synthesis/proofreading continues until the RNA primer is totally
degraded, and the gap is filled with DNA
❑DNA pol I uses its 5′→ 3′ polymerase activity to fill in gaps generated during
most types of DNA repair
Removal of RNA primer and filling of the resulting gaps by DNA polymerase I
Endonucleases and Exonucleases
Note;
❑Removal of RNA Primers and gap filling of the lagging strand.
‒ In Prokaryotes;—Removal of RNA Primer and Gap filling by DNA polymerase-I
‒ In Eukaryotes;- RNAse H and flap endonuclease 1 (FEN1) rather than by a DNA pol,
removes the primer
‒ DNAP δ fills the gap, where RNA Primer is removed.
❑Replisome
Multimeric proteins that assemble in the replication fork are called Replisome.
It includes:
• DNA helicase
• Primase
• DNA polymerase
• Single strand binding proteins
❑Primosome
Mobile complex between helicase and primase. The primosome makes the RNA primer
required for leading-strand synthesis and initiates Okazaki fragment formation in
discontinuous lagging-strand synthesis.
Proofreading newly synthesized DNA
❑Misreading of the templatesequence could result in deleterious, perhaps lethal,
mutations.
❑To insure replication fidelity, DNA pol III has a proofreading activity (3′→ 5′ exonuclease,)
in addition to its 5′→ 3′ polymerase activity.
❑As each nucleotide is added to the chain, DNA pol III checks to make certain the base of
the newly added nucleotide is, in fact, the complement of the base on the template
strand.
❑if the template base is C and the enzyme inserts an A instead of a G into the new chain,
the 3′→ 5′ exonuclease activity hydrolytically removes the misplaced nucleotide.
❑The 5′→ 3′ polymerase activity then replaces it with the correct nucleotide containing G
❑The 3′→ 5′ exonuclease activity removes the error in the direction opposite to
polymerization.
❑The 5′→ 3′ polymerase and 3′→ 5′ exonuclease domains are located on different
subunits of DNA pol III.
Exonuclease activity enables DNA polymerase III to proofread the newly synthesized DNA strand.
DNA replication illustration
Termination of DNA Replication
❑Consequently, in most normal human somatic cells, telomeres shorten with each
successive cell division
❑Once telomeres are shortened beyond some critical length, the cell is no longer able to
divide and is said to be senescent.
❑In germ cells and stem cells, as well as in cancer cells, telomeres do not shorten and the
cells do not senesce.
❑On the 5’ end of the newly synthesized linear DNA, RNA primer is
removed by RNAase H
❑This leaves a gap at the 5’ end of daughter strand.
❑In other words 3’ end of the leading strand is not synthesized.
❑This results in shortening of DNA with each cell division.
❑This is prevented by presence of Telomere and Telomerase
Telomerase (Telomere Terminal Transferase)
❑Reverse Transcriptase
❑For example, removal of the hydroxyl group from the 3′-carbon of the deoxyribose ring as in 2′,3′
dideoxyinosine (didanosine), or conversion of the deoxyribose to another sugar, such as
arabinose, prevents further chain elongation.
❑By blocking DNA replication, these compounds slow the division of rapidly growing cells and viruses
❑Cytosine arabinoside (cytarabine, or araC) has been used in anticancer chemotherapy, whereas adenine
arabinoside (vidarabine, or araA) is an antiviral agent.
❑Substitution on the sugar moiety, as seen in azidothymidine (AZT), also called zidovudine (ZDV), also
terminates DNA chain elongation.
❑These drugs are generally supplied as nucleosides, which are then converted to nucleotides by cellular
kinases
DNA REPAIR
❑DNA is subjected to a huge array of chemical, physical, and biological assaults on a
daily basis
❑ Repair of damaged DNA is critical for maintaining genomic integrity and thereby
preventing the propagation of mutations
❑The mutation can result in any of a number of deleterious effects, including loss of
control over the proliferation of the mutated cell, leading to cancer.
▪ Additional nucleotides at the 5′- and 3′-ends of the mismatch are also removed.
▪ The gap left by removal of the nucleotides is filled, using the sister strand as a
template, by a DNA pol, typically DNA pol III.
▪ The 3′-hydroxyl of the newly synthesized DNA is joined to the 5′-phosphate of the
remaining stretch of the original DNA strand by DNA ligase.
❑ Methyl-directed mismatch repair
in Escherichia coli.
▪ Mut S protein recognizes the
mismatch and recruits Mut L.
▪ The complex activates Mut H,
which cleaves the unmethylated
(daughter) strand.
Mutations to the mismatch repair proteins lead to cancer
• These intrastrand cross-links prevent DNA pol from replicating the DNA strand
beyond the site of dimer formation.
❑Bases can also be lost spontaneously. For example, ~10,000 purine bases are lost this way
per cell per day.
❑Lesions involving base alterations or loss can be corrected by base excision repair ([BER],
Steps involved in BER
• In BER, abnormal bases, such as uracil (which can occur in DNA by
either deamination of cytosine or improper use of dUTP instead of
dTTP during DNA synthesis) are recognized by specific DNA
glycosylases
❑dsDNA breaks cannot be corrected by the previously described strategy of excising the
damage on one strand and using the undamaged strand as a template for replacing the
missing nucleotide(s)
❑Instead, they are repaired by one of two systems.
1. nonhomologous end joining (NHEJ)
2. homologous recombination (HR),
❑ The choice between the two depends upon the phase of the cell cycle and the exact
type of DSB breaks to be repaired
❑ During the G0/G1 phases of the cell cycle, DSBs are corrected by the NHEJ pathway,
whereas during S, G2, and M phases of the cell cycle HR is utilized.
Nonhomologous end joining and Homologous recombination
• In nonhomologous end joining (NHEJ), a group of proteins mediates the recognition,
processing, and ligation of the ends of two DNA fragments.
• However, some DNA is lost in the process.
• Therefore, NHEJ is error prone and mutagenic.
• Defects in NHEJ are associated with a predisposition to cancer and immunodeficiency
syndromes.
• Homologous recombination (HR), uses the enzymes that normally perform genetic
recombination between homologous chromosomes during meiosis.
• This system is much less error prone (“error-free”) than NHEJ because any DNA that was
lost is replaced using homologous DNA as a template.
CHEMISTRY OF NUCLEOTIDES
Fig. 13.1: General structure of purine Fig. 13.2: General structure of pyrimidine
Table 13.1: Purines and pyrimidines
Base Purines Pyrimidines
Major bases in nucleic acids Adenine (A) Cytosine (C)
Guanine (G) Uracil (U)
Thymine (T)
Minor bases in nucleic acids 7-methyl guanine 5-methylcytosine
Dimethyl adenine 5-hydroxymethylcytosine
Metabolic intermediates and Hypoxanthine, xanthine, uric acid, caf- 5-fluorouracil
analogues feine, theophylline, allopurinol
Fig. 13.4: Structure of nucleotide (AMP)
Examples Functions
Adenosine triphosphate (ATP) and guanosine triphos- • High-energy compounds
phate (GTP)
Cyclic adenosine monophosphate (cAMP) and cyclic • Second messenger
guanosine monophosphate (cGMP)
3’-phosphoadenosine-5’-phosphosulfate (PAPS) • Sulfate donor
Nicotinamide adenine dinucleotide (NAD), nicotinamide • Coenzymes
adenine dinucleotide phosphate (NADP), CoASH
Uridine diphosphate (UDP)-glucose • Glycogen and UDP-glucuronic acid synthesis
UDP-glucuronic acid • Detoxification
Cytidine diphosphate (CDP)-choline • Synthesis of lecithin and sphingomyelin
4. Describe Watson-Crick model of DNA with a figure. What are the differences between
DNA and RNA?
i. In 1953, Watson and Crick proposed the DNA structure (Fig. 13.5).
ii. DNA consists of two polydeoxyribonucleotide strands coiled around the same axis to
form a right-handed helix. DNA is composed of deoxyribonucleotides (deoxyribose +
phosphate in diester linkage + bases like A, T, C, G).
iii. Polydeoxyribonucleotide strand is formed by phosphodiester bond between 3’-OH
group of one sugar and 5'-OH group of another sugar.
viii. Chargaff’s rule: It states that, total amount of purines are equal to total amount of
pyrimidines in a DNA double helix (A + G = T + C).
ix. The backbone of DNA is made up of alternating deoxyribose and phosphate groups
(hydrophilic). The hydrophobic nitrogenous bases are towards the core of double helix.
The bases are arranged perpendicular to the axis of helix.
x. The spatial relationship between two strands creates two types of grooves (major and
minor grooves). These grooves are the sites of interaction of DNA regulatory proteins.
xi. The diameter of the helix is 2 nm (20 Å).
xii. Each turn of the helix has 10 base pairs with a pitch of 3.4 nm (34 Å) and the bases
are 0.34 nm (3.4 Å) apart from each other along the helix.
Types of DNA
• B-form—DNA usually seen in human cells
• A-form—right-handed helix with 11 base pairs per turn
• Z-form—left-handed helix with 12 base pairs per turn.
Differences between DNA and RNA are given in Table 13.4.
Table 13.4: Differences between DNA and RNA
DNA RNA
Found in nucleus Found in nucleus and cytoplasm
Bases are A, T, G and C Bases are A, U, G and C
Nucleic Acid Chemistry
• 5’ cap: The eukaryotic mRNA is capped at the 5’ end by 7-methyl guanosine triphosphate,
which protects it from hydrolysis by 5’ exonuclease; it also helps in initiation of protein
synthesis
• Poly(A) tail: 3’ terminal contains a polymer of adenylate residues, which stabilizes the mRNA
• The mRNA is complementary to template strand of DNA.
Transfer RNA (Fig. 13.6)
i. Transfer RNA (tRNA) functions as an adapter, which brings a specific amino acid from
cytosol to the site of protein synthesis.
ii. It is small in size (75 nucleotides).
iii. Although there are 20 amino acids, around 32 tRNAs are found in humans.
Ribosomal RNA
i. Ribosomal RNAs (rRNAs) are the most abundant forms of RNA, which are associated with
ribosomes.
ii. They have catalytic activity (like enzymes). They have a role in translation. Ribosomal
subunits are given in the Table 13.5.
Table 13.5: Subunits of ribosome
Subunits Prokaryotes Eukaryotes
Larger subunit 50S 60S
Smaller subunit 30S 40S
Nucleic Acid Chemistry
Key Points
Nucleoside: Base (purine or pyrimidine) + pentose sugar (ribose or deoxyribose).
Nucleotide: Base (purine or pyrimidine) + pentose sugar (ribose or deoxyribose) + phosphate.
Purine analogues: Allopurinol and 6-mercaptopurine used in the treatment of gout and cancer
respectively.
Pyrimidine analogues: 5’-fluorouracil (thymidylate synthase inhibitor) used in the treatment of cancer.
Nucleoside analogues: Arabinosylcytosine and 5’-iododeoxyuridine are used in the treatment of
cancer and herpetic keratitis respectively.
Base pairing rule: Adenine-thymine is linked by two hydrogen bonds and guanine-cytosine are held
together by three hydrogen bonds.
Chargaff's rule: Total amount of purines are equal to total amount of pyrimidines in double helix
(A + G = T + C).
Melting temperature (Tm) for DNA: At 90oC, half of double-stranded DNA denatures into single-
stranded DNA.
Small nuclear RNA (snRNA): The snRNAs U 1, U2, U4, U5, U6 are required for splicing of hetero-
geneous nuclear RNA.
Unusual bases and nucleosides in the tRNA: Thymidine, dihydrouracil, hypoxanthine, pseudouridine.
Ch-13.indd 180 21-06-2014 11:51:33
Molecular Biology-I
REPLICATION
– DNA polymerase III: It is the main replication enzyme, also required for proofreading
(5’-3’ polymerase activity and 3’-5’ exonuclease activity).
• DNA ligase: Seals the nick in single strand as well as in Okazaki fragments.
iv. Proteins:
• dnaA: Binds to AT-rich region → unwinding of DNA
• Single-stranded DNA-binding proteins (SSB proteins): Prevent annealing of separated
DNA strands
• Primase: Initiates synthesis of short segment of RNA (RNA primer).
Molecular Biology-I
tion is a unique nucleotide sequence from where DNA replication begins. In prokaryotes,
there is a single ori, which consists of AT-rich region. In eukaryotes, multiple origins of
replication exist.
ii. Unwinding of double-stranded DNA to form 2 single-stranded DNA (ssDNA): dnaA
protein binds to AT-rich region in the origin of replication → local melting/unwinding
of dsDNA → short segment of ssDNA formed (required for initiation of DNA synthesis).
Single strand binding (SSB) proteins attach to each strand and prevent their annealing
(maintain DNA in single strand form). Separation of strands of DNA is required as DNA
polymerase binds to single strand of DNA.
iii. Formation of replication fork, synthesis of primer and initiation of DNA synthesis (Fig
15.1): Unwinding of DNA causes formation of replication fork → DNA helicase binds to the
fork → unwinding of adjacent double-stranded region → primase binds to DNA at 3’ end
of each strand → synthesis of short segment of RNA (RNA primer) → DNA polymerase
using RNA primer, initiates synthesis of daughter strand (complementary to template) in 5’
→ 3’ direction. Both parent strands are simultaneously replicated in the 5' → 3' direction.
The replication forks, thus, advance in opposite direction from their origin. This process
results in the formation of 'replication bubbles'.
Direction of DNA synthesis
a. Leading strand: DNA is synthesized continuously in 5’ → 3’ direction towards the
replication fork (Fig. 15.1) and it needs only one RNA primer.
b. Lagging strand: It is synthesized in short stretches in 5’ → 3’ direction, but away from
replication fork. These short stretches of discontinuous DNA are called Okazaki frag-
ments. It requires many RNA primers.
Unwinding of DNA during replication creates supercoils, which are relieved by topoi-
somerase I and II.
iv. Elongation
a. It is the process where there is sequential addition of deoxynucleotides via phosphodiester
bonds. First phosphodiester bond is formed between 3’–OH group of RNA primer and 5’
phosphate group of first entering deoxynucleotide. DNA polymerase (DNA pol III) elon-
gates new DNA strand by adding deoxynucleotides (dATP, dGTP, dTTP, dCTP) one at a
time, to the 3’ end of growing chain, complementary to bases in the template strand.
b. Proofreading of newly formed DNA: Any errors due to mismatched nucleotides during
replication are immediately repaired to prevent lethal mutations. This is mainly done by
DNA polymerase III and DNA polymerase I.
c. Excision of RNA primer.
• DNA polymerase I, which removes the RNA primer (5’-3’ exonuclease activity) and
synthesizes DNA that replaces RNA using 5’-3’ polymerase activity; it also proofreads
the new chain using 3’-5’ exonuclease activity
• DNA ligase: Catalyzes the formation of phosphodiester bond between DNA syn-
thesized by DNA polymerase III and that formed by DNA polymerase I using
energy (ATP).
v. In eukaryotes, an additional step occurs. The newly synthesized dsDNA reforms chromatin
structure.
Xeroderma Pigmentosum
Xeroderma pigmentosum is an autosomal recessive disorder with defective nucleotide ex-
cision repair due to deficiency of enzyme ultraviolet (UV) specific endonuclease. In this
condition, exposure to UV light can cause mutations in DNA (pyrimidine dimers), which may
lead to cancer.
Molecular Biology-I
2. What are Okazaki fragments?
Okazaki fragments are short segments of single-stranded DNA that are synthesized dis-
continuously on lagging strand during DNA replication (refer Fig. 15.1). DNA polymerase
I removes the RNA primers (5’-3’ exonuclease activity) between these fragments and syn-
thesize DNA that replaces RNA (5’-3’ polymerase activity). DNA ligase finally joins these
fragments (refer Elongation, p. 192).
3. Write a note on inhibitors of replication.
Inhibitors of replication, mechanism of action and therapeutic uses are given in Table 15.1.
Table 15.1: Inhibitors of replication
Inhibitor Mechanism of action Therapeutic use
Ciprofloxacin, novobiocin, nalidixic acid DNA gyrase inhibition Antibiotics
Etoposide, doxorubicin Inhibit topoisomerase II Anticancer agents
Cytosine arabinoside Prevents chain elongation Anticancer agent
Adenine arabinoside Prevents chain elongation Antiviral drug
Key Points
DNA replication occurs in S (synthetic) phase of cell cycle.
Proofreading: It is mainly done by DNA polymerase III and DNA polymerase I.
RNA primer (5–12 nucleotides long): Required for DNA synthesis; produced by primase.
Postreplicative modifications of DNA: These include methylation of DNA and mismatch repair.
Huntington's disease: Autosomal dominant disease with motor and cognitive dysfunction. This is
due to expansion of trinucleotide repeats (CAG), which codes for glutamate in huntingtin protein
(altering its function).
Xeroderma pigmentosum: It is an autosomal recessive disorder with defective nucleotide excision
repair due to deficiency of enzyme UV-specific endonuclease.
Fanconi anemia: Due to defective repair of interstrand DNA cross-links presenting with micro cephaly,
mental retardation, anemia and leukopenia.
Telomeres: It is the 3' end of mammalian DNA with 5'-TTAGGG-3' repeats. The number of these
repeats decreases with each cell division and indicates normal aging of cells. In germ cells, the
enzyme telomerase maintains the length of telomere.
Cancer and telomerase: Telomerase activity is found to be high in cancer cells, which make them
immortal and replicate indefinitely. Telomerase inhibitors are under development as potential anti-
cancer agents.
TRANSCRIPTION
Molecular Biology-I
Eukaryotic Promoters
About 25 nucleotides upstream of the transcription start site, similar to prokaryotes, a TATA
or Hogness box is present. Another consensus sequence CAAT box is present about 70–80
nucleotides upstream of transcription start site.
All these promoters help in deciding the origin of transcription by facilitating effective
binding of RNA polymerase.
5. Describe transcription process. Add a note on inhibitors of transcription.
Definition: Transcription is the process of synthesizing RNA from a DNA template. It takes
place in the 5' → 3' direction. The newly synthesized mRNA [primary transcript, heteroge-
neous nuclear RNA (hnRNA)] is identical to the other DNA strand—the coding strand (except
having uracil in place of thymine).
Requirements
• DNA to be copied
• RNA polymerase, RNAP (holoenzyme): Core enzyme (2α, 1β, 1β') + σ (sigma) factor. It
Molecular Biology-I
is the enzyme that synthesizes mRNA
• Termination factor—ρ (rho): For termination of transcription
• ATP
• Helicase: Unwinding of DNA during transcription
• Topoisomerase I and II: Remove supercoiling.
Steps in Transcription
Steps in transcription include initiation, elongation and termination.
i. Binding of RNAP to the template strand of DNA and formation of preinitiation complex:
RNA polymerase (holoenzyme) binds to promoter region (-35 sequence) of DNA. It then
moves on and binds to TATA box → causes local unwinding of DNA.
ii. Initiation of chain synthesis: The first nucleotide of RNA binds to nucleotide binding site
of 'b' subunit of RNA polymerase to form 5’ end of RNA. RNA polymerase moves to next
base on the template strand. A corresponding nucleotide binds to RNA polymerase and
phosphodiester bond is formed between the two nucleotides (Fig. 15.3).
iii. Clearance of promoter: Nucleotides continue to be added. Once RNA has 10–20 nucle-
otides, RNA polymerase leaves the promoter site (promoter clearance) and moves along
template strand.
iv. Elongation: After promoter clearance, elongation phase starts. New nucleotides are added to
the nascent mRNA complementary to the template strand. RNA polymerase uses ribonucle-
otides ATP, GTP, CTP and UTP. For addition of each ribonucleotide, energy equivalent to
two ATP is used (Table 15.2). Elongation complex containing RNA polymerase moves along
DNA template → unwinding of DNA downstream by RNAP.
Fig. 15.3: Transcription
Molecular Biology-I
Molecular Biology-I
DNA from RNA. It is present in retroviruses where it synthesizes viral DNA from viral
RNA (Fig. 15.4).
Applications
Molecular Biology-I
• 18S rRNA + proteins → 40S subunit; 40S + 60S → 80S ribosome.
Key Points
RNA polymerase has no proofreading activity, so transcription is more error prone compared to
replication.
Mushroom poisoning (α-amanitin): Inhibits RNA polymerase II and prevents elongation.
Spliceosome: It removes the introns and joins the exons to form mature mRNA.
Reverse transcriptase: It is the RNA-dependent DNA polymerase present in retroviruses, where
they copy the viral RNA genome into DNA.
TRANSLATION
Requirements for Translation
a. Amino acids: For synthesis of polypeptide chain.
b. Transfer RNA: At least one tRNA per amino acid.
c. Aminoacyl-tRNA synthetase: Required for attachment of amino acids to the specific tRNAs.
This requires energy (two ATP molecules).
d. Messenger RNA (mRNA): Has codons, which dictate synthesis of polypeptide chain.
e. Ribosomes (50S, 30S in prokaryotes; 40S, 60S in eukaryotes): Located in the cytosol as
free form or associated with endoplasmic reticulum.
• A, P and E sites on ribosome (p. 201) for binding tRNA
– A-site: For binding of incoming aminoacyl-tRNA as specified by codon at that site
Molecular Biology-I
– P-site: Has peptidyl tRNA (tRNA with newly synthesized chain of amino acids)
attached to it
– E-site: It is occupied by empty tRNA.
f. Initiation, elongation and termination factors.
g. Energy from:
• 2 ATP for binding of amino acids to specific tRNA
• 2 GTP for binding of aminoacyl-tRNA to A-site and translocation.
h. Binding between codon on mRNA and specific anticodon of tRNA: As per base pairing
rule (Fig. 15.7).
Fig. 15.7: Codon-anticodon interaction
Molecular Biology-I
a. Formation of 30S initiation complex: 30S ribosome + mRNA + aminoacyl-tRNA
specified by start codon + initiation factors (IF 1, 2, 3) → 30S initiation complex is
formed (Fig. 15.8).
b. Formation of 70S initiation complex (Fig. 15.9):
IF 1, 2, 3
50S ribosome + 30S initiation complex + GTP 70S initiation complex
Fig. 15.8: 30S initiation complex Fig. 15.9: 70S initiation complex
ii. Elongation:
a. Binding of appropriate tRNA to empty A-site: Elongation factors (EF-Tu, EF-Ts), in the
presence of GTP, will help in binding of appropriate tRNA with an amino acid to next
codon in the empty A-site (Fig. 15.10).
Molecular Biology-I
b. Peptide bond formation: Peptidyl transferase transfers the amino acid/peptide from the
P-site on to amino acid at the A-site and catalyzes peptide bond formation between the
amino acids. The tRNA at the P-site now does not have an amino acid (empty tRNA).
c. Translocation: Ribosome moves a distance of three nucleotides along mRNA in the
5’-3’ direction in the presence of GTP and EF-G. Thus, the empty tRNA, which was
at the P-site, now lies at E-site; peptidyl tRNA at A-site is now at P-site; A-site is
empty (Fig. 15.11).
Fig. 15.11: Translocation
Molecular Biology-I
ii. Initiation of protein synthesis:
a. Dissociation of ribosome → 40S subunit + 60S subunit.
b. Formation of 43S preinitiation complex:
GTP + initiation factor 2 + Met-tRNA (methionine is the first amino acid to be incorpo-
rated in protein synthesis)
Complex formed
Binds to 40S ribosomal subunit
43S preinitiation complex formed
c. Formation of 48S initiation complex:
mRNA binds to 43S preinitiation complex
48S initiation complex
The initiation (start) codon AUG on mRNA is identified by Kozak sequence.
The anticodon of Met-tRNA binds to initiation codon AUG on mRNA.
d. Formation of 80S initiation complex:
48S initiation complex binds with 60S ribosomal subunit
80S initiation complex formed
Met-tRNA is attached to P-site of ribosome. The A and E sites are free.
iii. Elongation: Addition of amino acids to the new growing peptide chain.
a. Binding of new, appropriate aminoacyl-tRNA to codon at acceptor A-site.
b. Formation of peptide bond by peptidyl transferase between new amino acid of tRNA
at A-site and amino acid attached to tRNA at P-site → transfer of amino acid/growing
peptide chain from P-site to amino acid at A-site. Thus, tRNA at P-site now does not
have any amino acid.
c. Translocation:
Ribosome moves along mRNA by 3 nucleotides (one codon) in the 5’ → 3’ direction
Movement of tRNA from P to E site from which it is released
Movement of peptidyl-tRNA from A to P site.
A-site is empty—a new aminoacyl-tRNA binds with codon of mRNA at this site.
Molecular Biology-I
iv. Termination:
Process of addition of amino acids continues till the termination (stop) codon on mRNA is
reached at the A-site. There is no tRNA with anticodon complementary to the stop codon
at A-site.
Releasing factor recognizes stop codon at A-site
Binds to A-site
Causes release of newly formed peptide chain, tRNA and mRNA from ribosomes
Dissociation of 80S ribosome → 60S + 40S subunits
10. Describe the properties of genetic code. Add a note on Wobble hypothesis.
• Genetic code is a sequence of 3 nucleotides (triplet code) in mRNA coding for an amino acid
• There are totally 64 different codons (43) from 4 nucleotides in different combinations
• AUG: Start codon, codes for methionine
• UAA, UAG, UGA: Stop codons, do not code for any amino acid—cause termination of
peptide synthesis.
• Non-overlapping and comma less: Codons are read in a continuous manner without any
punctuation
• It is degenerate (redundant): An amino acid may have more than one codon coding for
it, since there are 61 codons for 20 amino acids, e.g. arginine has six codons.
Wobble Hypothesis
Pairing between the bases at third position (last nucleotide) of codon on mRNA and first
position of anticodon of tRNA is non-traditional (not always as per Watson-Crick rule). So,
a single tRNA anticodon can bind to more than one codon (refer Fig. 15.7). For example,
the codons for glycine GGU, GGC and GGA pair with a single anticodon CCI of tRNA. The
base I at third position of anticodon can pair with either U, C or A of mRNA codon (Table
15.4). This is 'Wobble' [Note: Pairing between bases at first and second position of codon and
Molecular Biology-I
that of anticodon (second and third position) is as per Watson-Crick rule].
Table 15.4: Non-traditional base pairing between codon and anticodon
mRNA codon (5' → 3') for glycine GGU GGC GGA
tRNA anticodon (3' → 5') for glycine CCI CCI CCI
-
clease recognizes and cleaves a piece of DNA on both ends of the dimer → DNA polymerase
and DNA ligase together will repair and replace the gap with proper nucleotides. Defects in
this type of repair mechanism can lead to xeroderma pigmentosum, Cockayne's syndrome,
ataxia telangiectasia, etc.
-
Molecular Biology-II
Xeroderma Pigmentosum
Refer to Chapter 15, question number 1.
Mismatch Repair
i. Replication errors (escaped from proofreading) → mismatch of one to several bases (e.g.
instead of thymine, cytosine may be incorporated opposite to adenine).
Base mismatch on the daughter strand is recognized by endonuclease → cleavage of
strand near the defect → mismatched bases are removed from the daughter strand by
exonucleases → DNA polymerase I and DNA ligase repair and replace the gap with
appropriate nucleotides (Fig. 16.2).
ii. Defect in mismatch repair: May lead to hereditary non polyposis colon cancer.
-
Ch-16.indd 208 21-06-2014 11:52:07
Molecular Biology-II
Fig. 16.2: Mismatch repair
Repair Mechanism
• Non-homologous end joining (NHEJ): Two non-
homologous ends of the broken DNA strand are
brought together by proteins with some loss of
DNA Fig. 16.3: Base excision repair
• Homologous recombination: Two non homologous ends of the broken DNA strand are
-
brought together by proteins without loss of DNA.
3. Define and classify mutations with examples.
Definition: A mutation is a change in the sequence of nucleotides of DNA. It may or may
not alter the amino acid sequence of the protein encoded by that gene.
Chromosomal Mutations
• Philadelphia chromosome: Chromosomes 9–22 translocation → activation of c Abl; seen
-
in 80% of chronic myeloid leukemia cases
• Burkitt's lymphoma: 8–14 translocation → c Myc activation
Molecular Biology-II
-
• Non-Hodgkin's lymphoma: 14–18 translocation → activation of bcl 2 → suppression of
-
apoptosis.
Gene Mutation
• Point mutation
• Frameshift mutation
• Others.
Point mutation: Alteration in a single base is point mutation. This is of two types depend
ing on the type of base replaced.
a. Transition: Purine replaced by purine or pyrimidine replaced by pyrimidine.
For example, A ↔ G or C ↔ T.
b. Transversion: Purine replacing pyrimidine or pyrimidine replacing purine.
For example, A ↔ T or C ↔ G or A ↔ C or T ↔ G.
Effects of Point Mutation
a. Silent mutation: New codon formed after mutation codes for the same amino acid as
original codon. There is no change in the amino acid sequence and property of protein.
b. Missense mutation: New codon formed after mutation codes for a different amino acid.
This alters the amino acid sequence and may alter the function of protein. The effects
could be acceptable (function of protein not altered), partially acceptable (protein function
is partially affected) and non acceptable (non functional protein formed—could be fatal)
-
-
(Table 16.1).
c. Nonsense mutation: New codon formed after mutation codes for terminator codon leading
to premature termination of protein synthesis (Fig. 16.4).
Table 16.1: Effects of missense mutations (A, B = 'α' helical segments of globin chain)
Molecular Biology-II
Effects Normal hemoglobin Mutated hemoglobin
Acceptable B 61: AAA (lysine) B 61: AAU (asparagine): Hb Hikari
Partially acceptable B 6: GAG (glutamic acid) B 6: GUG (valine): Hb S (sickle cell disease)
Non-acceptable A 58: CAC (histidine) A 58: UAC (tyrosine): Hb M
Other Mutations
• Huntington's disease: CAG trinucleotide sequence is repeated many times → insertion of
many extra glutamine residues in the huntingtin protein → unstable proteins → accumula
tion of protein aggregates
• Fragile X syndrome and myotonic dystrophy: Trinucleotide expansion occurs in the un
translated portion of a gene → ↓ in the amount of protein produced
• Splice site mutation can affect removal of introns and protein formation. For example,
β-thalassemia (incorrect splicing of β-globin mRNA) and systemic lupus erythematosus
(SLE) (autoimmune antibodies against snRNP).
Molecular Biology-II
Molecular Biology-II
• Small amounts of lactose enter E. coli → converted to allolactose (inducer) → binds to
repressor proteins and prevents its interaction with operator gene → no obstruction for
movement of RNAP → protein (enzyme) synthesis occurs
• Absence of glucose → (+) adenylyl cyclase → ↑ cyclic adenosine monophosphate (cAMP) →
cAMP-catabolite activator protein (CAP) complex → binds to CAP site → ↑ ability of bound
RNAP to initiate transcription of lac Z, lac Y and lac A genes to produce β-galactosidase,
permease and thiogalactoside transacetylase, respectively. These enzymes help E. coli
to metabolize lactose to produce energy.
Fig. 16.6: Regulation of prokaryotic Lac operon system [MN: RPOS] (RNAP, ribonucleic acid polymerase)
c. When both glucose and lactose are available:
Operator site is free from inhibition as allolactose binds with repressor protein.
Glucose → ↓ cAMP → no CAP cAMP complex formation → RNAP cannot function
-
effectively → no protein (enzymes) formed → lactose cannot be utilized. Hence, glucose
is used first even though operator site is free. After all glucose is utilized by bacteria → ↑
cAMP → cAMP CAP complex formation → (+) RNAP → protein (enzyme) formation.
-
5. Briefly explain eukaryotic gene regulation.
Unlike prokaryotes, eukaryotic gene regulation is much complex. It can occur by six dif
ferent mechanisms.
a. Gene amplification: This occurs when a constant stimulus exists for a long time, e.g. dihydro
folate reductase gene gets amplified (increase in the number of DHFR genes) in a person on
antifolate drugs (for cancer).
b. Gene switching: When a person is exposed to a foreign antigen for the first time, immu
noglobulin M (IgM) is produced. Later, by gene switching for the same antigen, IgG is
produced.
c. Rearrangement of genes in DNA: Depending on the nature of antigens exposed, many types
of antibodies can be produced from a limited number of J, V and C segments. This is by
rearrangement of genes.
d. Control of transcription: This is done by cis and trans acting elements on DNA like enhanc
-
-
ers/silencers, hormones binding to hormone response elements, various proteins binding
to DNA, histone modifications, etc.
e. Post-transcriptional regulation: Post transcriptional modifications like 5’ capping, poly A tail,
-
splicing, etc. can regulate the stability of RNA. A transcribed monocistronic RNA can form
different proteins by RNA editing (alteration of a base in mRNA), e.g. apolipoproteins Apo
B100 and Apo B48 are formed from the same RNA.
f. Translational regulation: This is not a major mechanism in eukaryotes. For example, heme
can block its own synthesis by inhibiting the production of enzymes responsible for it.
Key Point
Cistron: Smallest unit of gene expression. It codes for one peptide or a subunit of protein.
Ch-16.indd 214 21-06-2014 11:52:07
e
e
e
e
m
m
m
m
m
co
Contd...
Reverse Transcriptase
• Temin and Baltimore isolated this enzyme in 1970 DNA Repair
• They are RNA Dependent DNA Polymerase damaging Defects in mecha- Disorder associ-
• Synthesize new DNA strand with RNA as template agents DNA nism ated
• Thus, they reverse Central dogma of molecular genetics Werner Syndrome
• These enzymes are important in RNA Viruses like Retroviruses (WS)
• Telomerase has reverse transcriptase activity. Rothmund-Thomson
m
Syndrome (RTS)
co
cross links gous Re- sia Like Disorder Major mechanism of DSB repair Major mechanism of DSB repair
co
REVIEW QUESTIONS
continuously synthesis
b. Multiple origins of replication are possible for Ans. b, c, d. (Harper 30/e page 381-387)
bacteria • Multiple ori in eukaryotes
e
e
e
e
m
m
m
m
m
co
• Each DNA Stand separate and each acts as template specific location
strand on which complementary strand is synthesized
co
discontinuous. (Harper 30/e page 381-387) Pol I Gap filling following DNA replication, repair,
and recombination
This questions means the common features between
eukaryotic and prokaryotic DNA replication. Contd...
e
e
e
e
m
m
m
m
m
co
e
e
e
m
m
m
m
m
co
10. In which of the following phase, DNA doubling 13. Action of telomerase is:
occurs: a. DNA repair
a. Gl phase b. Longevity of cell
b. S phase c. Breakdown of telomere
c. G2 phase d. None
d. M phase Ans. b. Longevity of cell-aging (Harper 30/e page 374)
m
d. Centromere
Topoisomerases Relieve torsional strain that results from
co
Transcriptases). c. mRNA
• Enzyme responsible for Telomere synthesis and d. tRNA
maintaining the length of telomere. Ans. a. ds DNA
e
e
e
e
m
m
m
m
m
co
c. RNA polymerase → DNA polymerase III → DNA damag- Defects in Repair Disorder
DNA polymerase I → DNA ligase ing agents DNA Mechanism associated
d. RNA polymerase → DNA polymerase III • Ionizing Ra- • Double N o n h o m o l o - Severe Com-
→ DNA ligase → exonuclease → DNA diations Strand gous End Join- b i n e d I m m u-
polymerase I • X-rays Breaks ing (NHEJ) nodeficiency
(SCID)
Ans. c. RNA Polymerase → DNA polymerase III → DNA • Antitumor • Single Strand
Breaks
polymerase I → DNA ligase (Harper 30/e page 381) drugs
Homologous Ataxia Tel-
• Intrastrand
• The correct sequence of enzymes is Helicase, Primase, Recombination angiectasia
cross links
DNA Polymerase III, DNA Polymerase I and on (HR) Like Disorder
• Interstrand Nijmen Break
lagging strand, DNA ligase cross links Syndrome
• Helicase, Primase, DNA Polymerase III on leading Bloom’s Syn-
m
Syndrome,
19. True about DNA polymerase in eukaryotes: Rothmund-
Thomson
Syndrome
a. Components are α, β, γ, δ, ε
Breast Cancer
b. β associated with repair Susceptibil-
c. γ associated with repair ity (BRCA 1,
BRCA 2)
d. δ associated with synthesis of mitochondria
DNA • UV light • Bulky Ad- Nucleotide Ex- Xeroderma
ducts cision Repair Pigmentosa
e. α is abundant amount • Chemicals
(NER) Cockayne Syn-
• Pyrimidine
Ans. a, b. Components are ..., β associated with ... Dimers
drome
Trichothio-
(Harper 30/e page 381)
dystrophy
m
b. No damage to DNA
DNA Polymerase have 5’ to 3’ Polymerase activity, 3’–5’
exonuclease (Proofreading) and 5’–3’exonuclease activity c. DNA hydrolysis
(repair) activity. d. Double stranded breaks
e
e
e
e
m
m
m
m
m
co
Ans. a. Formation of pyrimidine dimers • This is repaired by Nucleotide excision repair (NER)
(Harper 30/e page 390) • Defect in NER leads to Xeroderma Pigmentosa.
DNA lesions formed by UV light damage are Bulky 25. Which of the following is true regarding DNA
adducts and Pyrimidine Dimers. double-strand breaks repair pathway:
a. Homologous recombination require a long
23. Excessive ultraviolet (UV) radiation is harmful to
homologous sequence to guide repair
m